CompoAtlas

Celloré DHA 300

Natural health product licensed in Canada

Licence holder
Celavie Laboratoire Corporation
NPN or DIN-HM
80146838
Status
Active licence
Licence date
14 January 2026
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Citrate de triéthyle, (p)-hydroxybenzoate de méthyle, Gélatine, Copolymère d'acide méthacrylique, Mélange de concentré de tocophérols, Glycérine, Palmitate d'ascorbyle, (p)-hydroxybenzoate de propyle, Eau, Hydroxyde d'ammonium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support cognitive/brain health/function. Helps support/maintain (normal) heart/cardiovascular health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Source of docosahexaenoic acid (DHA) for the maintenance of good health. Source of eicosapentaenoic acid (EPA) for the maintenance of good health. Source of essential fatty acids for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80146838

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line